Impact Biomedical (IBO) Research & Development (2022 - 2026)
Impact Biomedical's Research & Development came in at $35,000 for Q3 2026, down 32.7% from $52,000 a year earlier and down 53.9% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Research & Development (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Impact Biomedical reported Research & Development of $267,000, up 118.9% year-over-year; for FY2025, it came in at $340,000, up 22.3% from FY2024.
- Research & Development carries a three-year compound annual growth rate of -34.8% (FY2022 to FY2025).
- Going back by year, Research & Development was $278,000 in FY2024 (-83.5%), $1.69 million in FY2023 (+37.4%) and $1.23 million in FY2022.
- The Q3 2026 figure represents the lowest quarterly Research & Development since Q4 2024.
- Year-over-year, Research & Development increased in 1 of the last six quarters, with an average decline of 34.2%.
- The fastest year-over-year change in Research & Development over five years came in Q2 2023 (growth of 29.1%), and the weakest in Q3 2024 (a decline of 77.0%).
- Business Quant data shows IBO's Research & Development at $76,000 (Q2 2026), $46,000 (Q1 2026) and $110,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 35,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35,000.00 |
| Jun 30, 2026 | 76,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 75,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 121,000.00 |
| Mar 31, 2024 | 183,000.00 |
| Dec 31, 2023 | 630,000.00 |
| Sep 30, 2023 | 357,000.00 |
| Jun 30, 2023 | 266,000.00 |
| Mar 31, 2023 | 179,000.00 |
| Dec 31, 2022 | 522,000.00 |
| Sep 30, 2022 | 330,000.00 |
| Jun 30, 2022 | 206,000.00 |
API Access
Impact Biomedical Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();